Page last updated: 2024-08-21

thiazolidines and Local Neoplasm Recurrence

thiazolidines has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Carnero, A; Fernández-Fernández, MC; García-Heredia, JM; Martinez-Pérez, J; Muñoz-Galván, S; Ortiz, MJ; Peinado-Serrano, J; Rivero, M1
Beijersbergen, RL; Bernards, R; Brunen, D; de Vries, RC; Lieftink, C1

Other Studies

2 other study(ies) available for thiazolidines and Local Neoplasm Recurrence

ArticleYear
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
    Cells, 2020, 04-25, Volume: 9, Issue:5

    Topics: Adult; Aged; Apoptosis; Biomarkers, Pharmacological; Biomarkers, Tumor; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Plasminogen Activator Inhibitor 1; Prognosis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rectal Neoplasms; Thiazolidines

2020
PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma.
    Molecular cancer therapeutics, 2018, Volume: 17, Issue:4

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Biphenyl Compounds; Cell Proliferation; CRISPR-Cas Systems; Female; Follow-Up Studies; Humans; Infant; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Neuroblastoma; Neurofibromin 1; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Survival Rate; Thiazolidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018